$BCRX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOCRYST PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in BIOCRYST PHARMACEUTICALS INC. Get notifications about new insider transactions in BIOCRYST PHARMACEUTICALS INC for free.
Page: < prev 1 ... 3 4 5 6 7 8 9 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 05 2010 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | VP Drug Discovery | Payment of Exercise | F | 6.46 | 6,137 | 39,645 | 52,738 | 58.9 K to 52.7 K (-10.42 %) |
| Dec 10 2009 | BCRX | BIOCRYST PHARMACEU ... | SANDERS CHARLES A | Director | Option Exercise | A | 6.70 | 8,333 | 55,831 | 8,333 | |
| Dec 02 2009 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | SR VP - CMO | Option Exercise | M | 2.58 | 4,167 | 10,751 | 129,167 | |
| Dec 02 2009 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | SR VP - CMO | Sell | S | 8.17 | 4,167 | 34,044 | 0 | 4.2 K to 0 (-100.00 %) |
| Dec 02 2009 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | SR VP - CMO | Buy | M | 2.58 | 4,167 | 10,751 | 4,167 | 0 to 4.2 K |
| Nov 25 2009 | BCRX | BIOCRYST PHARMACEU ... | FEATHERINGILL WILLIAM W | Director | Sell | S | 9.56 | 13,800 | 131,969 | 378,738 | 392.5 K to 378.7 K (-3.52 %) |
| Dec 02 2009 | BCRX | BIOCRYST PHARMACEU ... | FEATHERINGILL WILLIAM W | Director | Sell | S | 8.06 | 147,200 | 1,186,874 | 231,538 | 378.7 K to 231.5 K (-38.87 %) |
| Nov 23 2009 | BCRX | BIOCRYST PHARMACEU ... | FEATHERINGILL WILLIAM W | Director | Sell | S | 9.66 | 439,000 | 4,238,545 | 392,538 | 831.5 K to 392.5 K (-52.79 %) |
| Nov 04 2009 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | SR VP - CMO | Option Exercise | S | 2.58 | 4,167 | 10,751 | 133,334 | |
| Oct 28 2009 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | VP Drug Discovery | Sell | S | 10.85 | 6,400 | 69,422 | 39,362 | 45.8 K to 39.4 K (-13.99 %) |
| Oct 22 2009 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | VP Drug Discovery | Sell | S | 10.00 | 200 | 2,000 | 45,762 | 46 K to 45.8 K (-0.44 %) |
| Oct 21 2009 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | VP Drug Discovery | Sell | S | 10.00 | 3,400 | 34,000 | 45,962 | 49.4 K to 46 K (-6.89 %) |
| Oct 15 2009 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | SR VP - CMO | Option Exercise | S | 2.58 | 62,499 | 161,247 | 137,501 | |
| Oct 15 2009 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | SR VP - CMO | Sell | S | 8.92 | 6,000 | 53,540 | 0 | 6 K to 0 (-100.00 %) |
| Sep 24 2009 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | VP Drug Discovery | Sell | S | 9.14 | 20,000 | 182,720 | 49,362 | 69.4 K to 49.4 K (-28.83 %) |
| Jul 24 2009 | BCRX | BIOCRYST PHARMACEU ... | Mills Mike | Principal Accountin ... | Option Exercise | M | 3.26 | 1,500 | 4,890 | 4,275 | |
| Jul 24 2009 | BCRX | BIOCRYST PHARMACEU ... | Mills Mike | Principal Accountin ... | Sell | S | 8.26 | 1,500 | 12,390 | 0 | 1.5 K to 0 (-100.00 %) |
| Jul 24 2009 | BCRX | BIOCRYST PHARMACEU ... | Mills Mike | Principal Accountin ... | Buy | M | 3.26 | 1,500 | 4,890 | 1,500 | 0 to 1.5 K |
| Jul 21 2009 | BCRX | BIOCRYST PHARMACEU ... | Mills Mike | Principal Accountin ... | Sell | S | 6.00 | 968 | 5,808 | 0 | 968 to 0 (-100.00 %) |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Sell | S | 3.89 | 42,814 | 166,332 | 3,831,534 | 3.9 M to 3.8 M (-1.11 %) |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Sell | S | 3.86 | 110,557 | 427,203 | 3,874,348 | 4 M to 3.9 M (-2.77 %) |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Sell | S | 4.12 | 105,881 | 436,526 | 3,984,905 | 4.1 M to 4 M (-2.59 %) |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Sell | S | 4.30 | 20,567 | 88,465 | 4,090,786 | 4.1 M to 4.1 M (-0.50 %) |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Sell | S | 4.50 | 152,494 | 686,848 | 4,111,353 | 4.3 M to 4.1 M (-3.58 %) |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Sell | S | 4.45 | 84,619 | 376,851 | 4,263,847 | 4.3 M to 4.3 M (-1.95 %) |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 3.89 | 19,585 | 76,088 | 1,522,015 | 1.5 M to 1.5 M (-1.27 %) |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 3.86 | 50,574 | 195,423 | 1,541,600 | 1.6 M to 1.5 M (-3.18 %) |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 4.12 | 48,438 | 199,700 | 1,592,174 | 1.6 M to 1.6 M (-2.95 %) |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 4.30 | 9,409 | 40,471 | 1,640,612 | 1.7 M to 1.6 M (-0.57 %) |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 4.50 | 69,762 | 314,215 | 1,650,021 | 1.7 M to 1.7 M (-4.06 %) |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 4.45 | 38,710 | 172,395 | 1,719,783 | 1.8 M to 1.7 M (-2.20 %) |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | 14159 capital (GP), LLC | 10% Owner | Sell | S | 3.89 | 1,314 | 5,105 | 120,828 | 122.1 K to 120.8 K (-1.08 %) |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | 14159 capital (GP), LLC | 10% Owner | Sell | S | 3.86 | 3,392 | 13,107 | 122,142 | 125.5 K to 122.1 K (-2.70 %) |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | 14159 capital (GP), LLC | 10% Owner | Sell | S | 4.12 | 3,249 | 13,395 | 125,534 | 128.8 K to 125.5 K (-2.52 %) |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | 14159 capital (GP), LLC | 10% Owner | Sell | S | 4.30 | 631 | 2,714 | 128,783 | 129.4 K to 128.8 K (-0.49 %) |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | 14159 capital (GP), LLC | 10% Owner | Sell | S | 4.50 | 4,677 | 21,066 | 129,414 | 134.1 K to 129.4 K (-3.49 %) |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | 14159 capital (GP), LLC | 10% Owner | Sell | S | 4.45 | 2,597 | 11,566 | 134,091 | 136.7 K to 134.1 K (-1.90 %) |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 3.89 | 3,124 | 12,137 | 71,997 | 75.1 K to 72 K (-4.16 %) |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 3.86 | 8,067 | 31,172 | 75,121 | 83.2 K to 75.1 K (-9.70 %) |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 4.12 | 7,726 | 31,853 | 83,188 | 90.9 K to 83.2 K (-8.50 %) |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 4.30 | 1,500 | 6,452 | 90,914 | 92.4 K to 90.9 K (-1.62 %) |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 4.50 | 11,128 | 50,122 | 92,414 | 103.5 K to 92.4 K (-10.75 %) |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 4.45 | 6,174 | 27,496 | 103,542 | 109.7 K to 103.5 K (-5.63 %) |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | FEATHERINGILL WILLIAM W | Director | Option Exercise | A | 3.96 | 15,000 | 59,400 | 15,000 | |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | S | 3.89 | 835 | 3,244 | 17,241 | 18.1 K to 17.2 K (-4.62 %) |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | S | 3.86 | 2,157 | 8,335 | 18,076 | 20.2 K to 18.1 K (-10.66 %) |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | S | 4.12 | 2,065 | 8,514 | 20,233 | 22.3 K to 20.2 K (-9.26 %) |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | S | 4.30 | 402 | 1,729 | 22,298 | 22.7 K to 22.3 K (-1.77 %) |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | S | 4.50 | 2,975 | 13,400 | 22,700 | 25.7 K to 22.7 K (-11.59 %) |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | S | 4.45 | 1,651 | 7,353 | 25,675 | 27.3 K to 25.7 K (-6.04 %) |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | SEIDENBERG BETH C | Director | Option Exercise | A | 3.96 | 15,000 | 59,400 | 15,000 | |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | HIGGINS JOHN L | Director | Option Exercise | A | 3.96 | 15,000 | 59,400 | 15,000 | |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | HOROVITZ ZOLA P | Director | Option Exercise | A | 3.96 | 15,000 | 59,400 | 15,000 | |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Erck Stanley C | Director | Option Exercise | A | 3.96 | 15,000 | 59,400 | 15,000 | |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Biggar Stephen R | Director | Option Exercise | A | 3.96 | 15,000 | 59,400 | 15,000 | |
| Mar 16 2009 | BCRX | BIOCRYST PHARMACEU ... | Erck Stanley C | Director | Buy | P | 1.22 | 40,000 | 48,880 | 40,000 | 0 to 40 K |
| Mar 04 2009 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Option Exercise | A | 1.20 | 279,600 | 335,520 | 279,600 | |
| Mar 05 2009 | BCRX | BIOCRYST PHARMACEU ... | FEATHERINGILL WILLIAM W | Director | Buy | P | 9.00 | 5,000 | 45,000 | 1,808,572 | 1.8 M to 1.8 M (+0.28 %) |
| Mar 05 2009 | BCRX | BIOCRYST PHARMACEU ... | FEATHERINGILL WILLIAM W | Director | Buy | P | 9.00 | 6,000 | 54,000 | 1,803,572 | 1.8 M to 1.8 M (+0.33 %) |
| Mar 04 2009 | BCRX | BIOCRYST PHARMACEU ... | Grant Stuart | SR VP & CFO | Option Exercise | A | 1.20 | 125,000 | 150,000 | 125,000 | |
| Mar 04 2009 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | VP Drug Discovery | Option Exercise | A | 1.20 | 100,000 | 120,000 | 100,000 | |
| Mar 04 2009 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | SR VP - CMO | Option Exercise | A | 1.20 | 22,500 | 27,000 | 22,500 | |
| Mar 04 2009 | BCRX | BIOCRYST PHARMACEU ... | McCullough David | VP | Option Exercise | A | 1.20 | 70,000 | 84,000 | 70,000 | |
| Feb 03 2009 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | SR VP - CMO | Buy | P | 1.62 | 3,000 | 4,845 | 3,000 | 0 to 3 K |
| Mar 04 2009 | BCRX | BIOCRYST PHARMACEU ... | Mills Mike | Principal Accountin ... | Option Exercise | A | 1.20 | 6,000 | 7,200 | 6,000 | |
| Feb 03 2009 | BCRX | BIOCRYST PHARMACEU ... | Grant Stuart | SR VP & CFO | Buy | P | 1.62 | 3,000 | 4,845 | 6,000 | 3 K to 6 K (+100.00 %) |
| Feb 03 2009 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Buy | P | 1.62 | 3,000 | 4,845 | 103,603 | 100.6 K to 103.6 K (+2.98 %) |
| Dec 23 2008 | BCRX | BIOCRYST PHARMACEU ... | Erck Stanley C | Director | Option Exercise | A | 1.49 | 8,333 | 12,416 | 8,333 | |
| Dec 02 2008 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Buy | P | 1.48 | 55,000 | 81,450 | 155,603 | 100.6 K to 155.6 K (+54.67 %) |
| Nov 24 2008 | BCRX | BIOCRYST PHARMACEU ... | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 0.98 | 10 | 10 | 109,716 | 109.7 K to 109.7 K (+0.01 %) |
| Nov 24 2008 | BCRX | BIOCRYST PHARMACEU ... | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 0.91 | 43 | 39 | 109,706 | 109.7 K to 109.7 K (+0.04 %) |
| Nov 24 2008 | BCRX | BIOCRYST PHARMACEU ... | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 1.00 | 422 | 422 | 109,663 | 109.2 K to 109.7 K (+0.39 %) |
| Nov 24 2008 | BCRX | BIOCRYST PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 0.98 | 7,401 | 7,237 | 4,348,466 | 4.3 M to 4.3 M (+0.17 %) |
| Nov 24 2008 | BCRX | BIOCRYST PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 0.91 | 31,071 | 28,402 | 4,341,065 | 4.3 M to 4.3 M (+0.72 %) |
| Nov 24 2008 | BCRX | BIOCRYST PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 1.00 | 303,517 | 303,517 | 4,309,994 | 4 M to 4.3 M (+7.58 %) |
| Nov 24 2008 | BCRX | BIOCRYST PHARMACEU ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 0.98 | 2,339 | 2,287 | 1,758,493 | 1.8 M to 1.8 M (+0.13 %) |
| Nov 24 2008 | BCRX | BIOCRYST PHARMACEU ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 0.91 | 9,831 | 8,987 | 1,756,154 | 1.7 M to 1.8 M (+0.56 %) |
| Nov 24 2008 | BCRX | BIOCRYST PHARMACEU ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 1.00 | 96,033 | 96,033 | 1,746,323 | 1.7 M to 1.7 M (+5.82 %) |
| Nov 24 2008 | BCRX | BIOCRYST PHARMACEU ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 0.98 | 49 | 48 | 27,326 | 27.3 K to 27.3 K (+0.18 %) |
| Nov 24 2008 | BCRX | BIOCRYST PHARMACEU ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 0.91 | 207 | 189 | 27,277 | 27.1 K to 27.3 K (+0.76 %) |
| Nov 24 2008 | BCRX | BIOCRYST PHARMACEU ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 1.00 | 2,028 | 2,028 | 27,070 | 25 K to 27.1 K (+8.10 %) |
| Nov 24 2008 | BCRX | BIOCRYST PHARMACEU ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 0.98 | 201 | 197 | 136,688 | 136.5 K to 136.7 K (+0.15 %) |
| Nov 24 2008 | BCRX | BIOCRYST PHARMACEU ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 0.91 | 848 | 775 | 136,487 | 135.6 K to 136.5 K (+0.63 %) |
| Nov 24 2008 | BCRX | BIOCRYST PHARMACEU ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 1.00 | 8,278 | 8,278 | 135,639 | 127.4 K to 135.6 K (+6.50 %) |
| Nov 03 2008 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Buy | P | 1.75 | 22,900 | 40,075 | 100,603 | 77.7 K to 100.6 K (+29.47 %) |
| Nov 03 2008 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Buy | P | 1.74 | 2,100 | 3,654 | 77,703 | 75.6 K to 77.7 K (+2.78 %) |
| Aug 13 2008 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Buy | P | 3.10 | 2,300 | 7,124 | 75,603 | 73.3 K to 75.6 K (+3.14 %) |
| Aug 13 2008 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Buy | P | 2.95 | 7,700 | 22,736 | 73,303 | 65.6 K to 73.3 K (+11.74 %) |
| Aug 04 2008 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Buy | P | 2.82 | 240 | 677 | 65,603 | 65.4 K to 65.6 K (+0.37 %) |
| Aug 04 2008 | BCRX | BIOCRYST PHARMACEU ... | Grant Stuart | SR VP & CFO | Buy | P | 2.82 | 3,000 | 8,466 | 3,000 | 0 to 3 K |
| Aug 04 2008 | BCRX | BIOCRYST PHARMACEU ... | DARWIN MICHAEL A | Principal Accountin ... | Buy | P | 2.82 | 1,709 | 4,823 | 3,048 | 1.3 K to 3 K (+127.63 %) |
| Jul 03 2008 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | SR VP - CMO | Option Exercise | A | 2.58 | 200,000 | 516,000 | 200,000 | |
| May 23 2008 | BCRX | BIOCRYST PHARMACEU ... | STEER RANDOLPH C | Director | Option Exercise | A | 3.12 | 15,000 | 46,800 | 15,000 | |
| May 23 2008 | BCRX | BIOCRYST PHARMACEU ... | SEIDENBERG BETH C | Director | Option Exercise | A | 3.12 | 15,000 | 46,800 | 15,000 | |
| May 23 2008 | BCRX | BIOCRYST PHARMACEU ... | McCullough David | VP | Option Exercise | A | 0.00 | 14,439 | 0 | 14,439 | |
| May 23 2008 | BCRX | BIOCRYST PHARMACEU ... | HOROVITZ ZOLA P | Director | Option Exercise | A | 3.12 | 15,000 | 46,800 | 15,000 | |
| May 23 2008 | BCRX | BIOCRYST PHARMACEU ... | HIGGINS JOHN L | Director | Option Exercise | A | 3.12 | 15,000 | 46,800 | 15,000 | |
| May 23 2008 | BCRX | BIOCRYST PHARMACEU ... | Grant Stuart | SR VP & CFO | Option Exercise | A | 0.00 | 24,839 | 0 | 24,839 | |
| May 23 2008 | BCRX | BIOCRYST PHARMACEU ... | FEATHERINGILL WILLIAM W | Director | Option Exercise | A | 3.12 | 15,000 | 46,800 | 15,000 | |
| May 23 2008 | BCRX | BIOCRYST PHARMACEU ... | Biggar Stephen R | Director | Option Exercise | A | 3.12 | 15,000 | 46,800 | 15,000 | |
| Mar 18 2008 | BCRX | BIOCRYST PHARMACEU ... | McCullough David | VP | Option Exercise | A | 3.26 | 17,250 | 56,235 | 17,250 | |
| Mar 18 2008 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Option Exercise | A | 3.26 | 60,750 | 198,045 | 60,750 | |
| Mar 18 2008 | BCRX | BIOCRYST PHARMACEU ... | Grant Stuart | SR VP & CFO | Option Exercise | A | 3.26 | 75,000 | 244,500 | 75,000 | |
| Mar 18 2008 | BCRX | BIOCRYST PHARMACEU ... | DARWIN MICHAEL A | Principal Accountin ... | Option Exercise | A | 3.26 | 9,617 | 31,351 | 9,617 | |
| Mar 18 2008 | BCRX | BIOCRYST PHARMACEU ... | BENNETT J CLAUDE | Chief Operating Off ... | Option Exercise | A | 3.26 | 17,000 | 55,420 | 17,000 | |
| Feb 04 2008 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Buy | P | 3.50 | 3,000 | 10,506 | 65,363 | 62.4 K to 65.4 K (+4.81 %) |
| Feb 04 2008 | BCRX | BIOCRYST PHARMACEU ... | DARWIN MICHAEL A | Principal Accountin ... | Buy | P | 3.50 | 1,339 | 4,689 | 1,339 | 0 to 1.3 K |
| Aug 29 2007 | BCRX | BIOCRYST PHARMACEU ... | Grant Stuart | SR VP & CFO | Option Exercise | A | 11.39 | 200,000 | 2,278,000 | 200,000 | |
| Sep 06 2007 | BCRX | BIOCRYST PHARMACEU ... | BENNETT J CLAUDE | Chief Operating Off ... | Option Exercise | M | 6.50 | 8,437 | 54,841 | 0 | |
| Sep 06 2007 | BCRX | BIOCRYST PHARMACEU ... | BENNETT J CLAUDE | Chief Operating Off ... | Option Exercise | M | 6.25 | 11,563 | 72,269 | 8,088 | |
| Sep 06 2007 | BCRX | BIOCRYST PHARMACEU ... | BENNETT J CLAUDE | Chief Operating Off ... | Sell | S | 12.00 | 20,000 | 240,000 | 65,730 | 85.7 K to 65.7 K (-23.33 %) |
| Sep 06 2007 | BCRX | BIOCRYST PHARMACEU ... | BENNETT J CLAUDE | Chief Operating Off ... | Buy | M | 6.50 | 8,437 | 54,841 | 85,730 | 77.3 K to 85.7 K (+10.92 %) |
| Sep 06 2007 | BCRX | BIOCRYST PHARMACEU ... | BENNETT J CLAUDE | Chief Operating Off ... | Buy | M | 6.25 | 11,563 | 72,269 | 77,293 | 65.7 K to 77.3 K (+17.59 %) |
| Aug 14 2007 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Buy | P | 9.86 | 2,650 | 26,129 | 62,363 | 59.7 K to 62.4 K (+4.44 %) |
| Aug 14 2007 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Buy | P | 9.95 | 3,700 | 36,815 | 59,713 | 56 K to 59.7 K (+6.61 %) |
| Aug 14 2007 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Buy | P | 9.94 | 1,500 | 14,910 | 56,013 | 54.5 K to 56 K (+2.75 %) |
| Aug 14 2007 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Buy | P | 9.87 | 356 | 3,514 | 54,513 | 54.2 K to 54.5 K (+0.66 %) |
| Aug 14 2007 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Buy | P | 9.85 | 144 | 1,418 | 54,157 | 54 K to 54.2 K (+0.27 %) |
| Aug 14 2007 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Buy | P | 9.84 | 50 | 492 | 54,013 | 54 K to 54 K (+0.09 %) |
| Aug 14 2007 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Buy | P | 9.81 | 1,400 | 13,734 | 53,963 | 52.6 K to 54 K (+2.66 %) |
| Aug 14 2007 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Buy | P | 9.80 | 100 | 980 | 52,563 | 52.5 K to 52.6 K (+0.19 %) |
| Aug 08 2007 | BCRX | BIOCRYST PHARMACEU ... | FEATHERINGILL WILLIAM W | Director | Option Exercise | P | 10.25 | 315,985 | 3,238,846 | 315,985 | |
| Aug 08 2007 | BCRX | BIOCRYST PHARMACEU ... | FEATHERINGILL WILLIAM W | Director | Buy | P | 7.80 | 831,538 | 6,485,996 | 831,538 | 0 to 831.5 K |
| Aug 02 2007 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | CEO | Buy | P | 7.06 | 2,463 | 17,376 | 52,463 | 50 K to 52.5 K (+4.93 %) |
| Aug 02 2007 | BCRX | BIOCRYST PHARMACEU ... | Nugent Jonathan M | VP Corp Communicati ... | Buy | P | 7.06 | 285 | 2,011 | 508 | 223 to 508 (+127.80 %) |
| Aug 02 2007 | BCRX | BIOCRYST PHARMACEU ... | ALEXANDER W JAMES | SR. VP, Chief Medic ... | Buy | P | 7.06 | 2,374 | 16,749 | 3,659 | 1.3 K to 3.7 K (+184.75 %) |
| May 18 2007 | BCRX | BIOCRYST PHARMACEU ... | DARWIN MICHAEL A | Chief Financial Off ... | Option Exercise | A | 7.98 | 12,244 | 97,707 | 12,244 | |
| May 18 2007 | BCRX | BIOCRYST PHARMACEU ... | RIGGS RANDALL B | Senior VP Business ... | Option Exercise | A | 7.98 | 23,868 | 190,467 | 23,868 | |
| May 18 2007 | BCRX | BIOCRYST PHARMACEU ... | BENNETT J CLAUDE | President | Option Exercise | A | 7.98 | 28,288 | 225,738 | 28,288 | |
| May 18 2007 | BCRX | BIOCRYST PHARMACEU ... | Nugent Jonathan M | VP Corp Communicati ... | Option Exercise | A | 7.98 | 9,267 | 73,951 | 9,267 | |
| May 18 2007 | BCRX | BIOCRYST PHARMACEU ... | ALEXANDER W JAMES | SR. VP, Chief Medic ... | Option Exercise | A | 7.98 | 20,425 | 162,992 | 20,425 | |
| May 17 2007 | BCRX | BIOCRYST PHARMACEU ... | HIGGINS JOHN L | Director | Option Exercise | A | 7.98 | 15,000 | 119,700 | 15,000 | |
| May 17 2007 | BCRX | BIOCRYST PHARMACEU ... | HOROVITZ ZOLA P | Director | Option Exercise | A | 7.98 | 15,000 | 119,700 | 15,000 | |
| May 17 2007 | BCRX | BIOCRYST PHARMACEU ... | SEIDENBERG BETH C | Director | Option Exercise | A | 7.98 | 15,000 | 119,700 | 15,000 | |
| May 17 2007 | BCRX | BIOCRYST PHARMACEU ... | FEATHERINGILL WILLIAM W | Director | Option Exercise | A | 7.98 | 15,000 | 119,700 | 15,000 | |
| May 17 2007 | BCRX | BIOCRYST PHARMACEU ... | Biggar Stephen R | Director | Option Exercise | A | 7.98 | 15,000 | 119,700 | 15,000 | |
| May 17 2007 | BCRX | BIOCRYST PHARMACEU ... | SHERRILL JOSEPH H JR | Director | Option Exercise | A | 7.98 | 15,000 | 119,700 | 15,000 | |
| May 17 2007 | BCRX | BIOCRYST PHARMACEU ... | SPENCER WILLIAM M III | Director | Option Exercise | A | 7.98 | 15,000 | 119,700 | 15,000 | |
| May 17 2007 | BCRX | BIOCRYST PHARMACEU ... | STEER RANDOLPH C | Director | Option Exercise | A | 7.98 | 15,000 | 119,700 | 15,000 | |
| Apr 04 2007 | BCRX | BIOCRYST PHARMACEU ... | McCullough David | VP | Option Exercise | A | 8.20 | 150,000 | 1,230,000 | 150,000 | |
| Apr 04 2007 | BCRX | BIOCRYST PHARMACEU ... | McCullough David | VP | Grant | A | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
| Apr 03 2007 | BCRX | BIOCRYST PHARMACEU ... | RIGGS RANDALL B | Senior VP Business ... | Option Exercise | A | 8.37 | 5,000 | 41,850 | 5,000 | |
| Mar 22 2007 | BCRX | BIOCRYST PHARMACEU ... | BUGG CHARLES E | Director | Option Exercise | A | 9.23 | 3,333 | 30,764 | 3,333 | |
| Feb 27 2007 | BCRX | BIOCRYST PHARMACEU ... | BENNETT J CLAUDE | President | Option Exercise | M | 6.25 | 10,549 | 65,931 | 19,651 | |
| Feb 27 2007 | BCRX | BIOCRYST PHARMACEU ... | BENNETT J CLAUDE | President | Option Exercise | M | 6.09 | 4,622 | 28,166 | 24,078 | |
| Feb 27 2007 | BCRX | BIOCRYST PHARMACEU ... | BENNETT J CLAUDE | President | Option Exercise | M | 1.18 | 1,000 | 1,180 | 14,545 | |
| Feb 27 2007 | BCRX | BIOCRYST PHARMACEU ... | BENNETT J CLAUDE | President | Buy | M | 6.25 | 10,549 | 65,931 | 65,730 | 55.2 K to 65.7 K (+19.12 %) |
| Feb 27 2007 | BCRX | BIOCRYST PHARMACEU ... | BENNETT J CLAUDE | President | Buy | M | 6.09 | 4,622 | 28,166 | 55,181 | 50.6 K to 55.2 K (+9.14 %) |
| Feb 27 2007 | BCRX | BIOCRYST PHARMACEU ... | BENNETT J CLAUDE | President | Buy | M | 1.18 | 1,000 | 1,180 | 50,559 | 49.6 K to 50.6 K (+2.02 %) |
| Feb 02 2007 | BCRX | BIOCRYST PHARMACEU ... | Nugent Jonathan M | VP Corp Communicati ... | Buy | P | 8.64 | 223 | 1,928 | 223 | 0 to 223 |